Literature DB >> 12476050

Experimental modulation of cell-cell adhesion, invasiveness and differentiation in trophoblast cells.

Hans-Peter Hohn1, Hans-Werner Denker.   

Abstract

The establishment of pregnancy in the human decisively depends on the competence of the early trophoblast to interact during implantation with (1). the uterine epithelium and subsequently (2). with the endometrial stroma and blood vessels. In the interaction with uterine epithelium cell-to-cell adhesion appears to be a critical element, involving initially (and astonishingly) apical cell poles of both epithelia. The subsequent invasion of the stroma includes both adhesive interactions with and degradation of extracellular matrix. How these different processes are regulated in detail remains largely unknown. While the invasiveness of the trophoblast is known to be regulated in local and temporal terms it has remained unclear so far whether trophoblast adhesiveness to cells and/or matrix is subject to a coupled regulation or whether both properties involve different, maybe sequentially effective, control mechanisms. It is also not known how the regulation of these activities is related to the differentiation pathways leading to the formation of noninvasive villous trophoblast serving endocrine as well as nutritive functions. This communication reviews experiments using normal cytotrophoblast cells isolated from first trimester or term placentae as well as malignant trophoblast (choriocarcinoma) cells treated with a panel of compounds known to modulate cell differentiation [retinoic acid, methotrexate, dibutyryl-cAMP, phorbol-(12-myristoyl-13-acetyl)-diester]. Parameters indicative of trophoblast differentiation [in particular chorionic gonadotrophin (hCG) secretion] as well as adhesion to uterine epithelial cells and invasion into extracellular matrix in vitro were monitored. While expression of differentiation parameters was increased by all drug treatments, adhesion to uterine epithelial cells in vitro was reduced. Modulation of invasiveness, however, followed a different pattern: while it was reduced in normal trophoblast cells it was even increased in choriocarcinoma cells with various substances. The response of cells with respect to production of extracellular matrix proteins or matrix-degrading proteinases showed a complex pattern that again lacked a stringent correlation with hCG production and adhesion, and in addition also with invasive behavior. These results suggest that adhesiveness of trophoblast to uterine epithelial cells and invasiveness into the uterine stroma (extracellular matrix) are subject to different control mechanisms. They support the view that trophoblast-endometrium interactions involve a cascade of various adhesion and migration processes whose cellular and molecular basis is complex but accessible to experimental investigation using a variety of available in vitro systems. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12476050     DOI: 10.1159/000066965

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  9 in total

1.  Hormonal regulation of the Menkes and Wilson copper-transporting ATPases in human placental Jeg-3 cells.

Authors:  Belinda Hardman; Agnes Michalczyk; Mark Greenough; James Camakaris; Julian F B Mercer; M Leigh Ackland
Journal:  Biochem J       Date:  2007-03-01       Impact factor: 3.857

Review 2.  The role of insulin-like growth factor 2 mRNA binding proteins in female reproductive pathophysiology.

Authors:  Xiao Xu; Hao-Ran Shen; Jia-Rong Zhang; Xue-Lian Li
Journal:  Reprod Biol Endocrinol       Date:  2022-06-15       Impact factor: 4.982

3.  IgG expression in trophoblasts derived from placenta and gestational trophoblastic disease and its role in regulating invasion.

Authors:  Mei Yang; Chunfang Ha; Dan Liu; Yonghui Xu; Yuan Ma; Yufeng Liu; Yan Nian
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

4.  In vitro fertilization and embryo culture strongly impact the placental transcriptome in the mouse model.

Authors:  Patricia Fauque; Françoise Mondon; Franck Letourneur; Marie-Anne Ripoche; Laurent Journot; Sandrine Barbaux; Luisa Dandolo; Catherine Patrat; Jean-Philippe Wolf; Pierre Jouannet; Hélène Jammes; Daniel Vaiman
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

5.  Effects of galectin-3 inhibition on endometrial cell cycle and adhesion.

Authors:  Caixia Lei; Wei Zhang; Xiaowei Sun; Guoping Du; Li Wang; Yinkun Liu
Journal:  Front Med China       Date:  2007-10

6.  Role of IGF2BP3 in trophoblast cell invasion and migration.

Authors:  W Li; D Liu; W Chang; X Lu; Y-L Wang; H Wang; C Zhu; H-Y Lin; Y Zhang; J Zhou; H Wang
Journal:  Cell Death Dis       Date:  2014-01-23       Impact factor: 8.469

7.  Specific trophoblast transcripts transferred by extracellular vesicles affect gene expression in endometrial epithelial cells and may have a role in embryo-maternal crosstalk.

Authors:  Masoumeh Es-Haghi; Kasun Godakumara; Annika Häling; Freddy Lättekivi; Arina Lavrits; Janeli Viil; Aneta Andronowska; Tamer Nafee; Victoria James; Ülle Jaakma; Andres Salumets; Alireza Fazeli
Journal:  Cell Commun Signal       Date:  2019-11-14       Impact factor: 5.712

8.  Expression of matrix metalloproteinase 12 is highly specific for non-proliferating invasive trophoblasts in the first trimester and temporally regulated by oxygen-dependent mechanisms including HIF-1A.

Authors:  Ursula Hiden; Christian P Eyth; Alejandro Majali-Martinez; Gernot Desoye; Carmen Tam-Amersdorfer; Berthold Huppertz; Nassim Ghaffari Tabrizi-Wizsy
Journal:  Histochem Cell Biol       Date:  2017-10-09       Impact factor: 4.304

9.  Trophoblast differentiation, invasion and hormone secretion in a three-dimensional in vitro implantation model with rhesus monkey embryos.

Authors:  T Arthur Chang; Gennadiy I Bondarenko; Behzad Gerami-Naini; Jessica G Drenzek; Maureen Durning; Mark A Garthwaite; Jenna Kropp Schmidt; Thaddeus G Golos
Journal:  Reprod Biol Endocrinol       Date:  2018-03-16       Impact factor: 5.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.